SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-104928
Filing Date
2020-09-14
Accepted
2020-09-14 17:25:27
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 tm2030180-1_s3.htm S-3 444801
2 SEPTEMBER 14, 2020 tm2030180d2_ex5-1.htm EX-5.1 35660
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM tm2030180d2_ex23-1.htm EX-23.1 3803
4 GRAPHIC lg_leaptherapeutic-4c.jpg GRAPHIC 351149
  Complete submission text file 0001104659-20-104928.txt   913172
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-248797 | Film No.: 201174017
SIC: 2834 Pharmaceutical Preparations